- Home
- » Tags
- » Iduronidase
Top View
- (INN) for Biological and Biotechnological Substances
- Induced Glycosaminoglycan and Sphingolipid Accumulation
- Orphan Drug Designations and Approvals List As of 12-02-2013 Governs January 1, 2014
- A Fungal Pathogen Causing Phomopsis Seed Decay in Soybean Shuxian Li1*† , Omar Darwish2†, Nadim W
- Orphan Drug Designation List
- Identifying Novel Lignocellulosic Processing Enzymes from Cellulomonas Fimi Using Transcriptomic, Proteomic and Evolution Adaptive Studies
- 5.01.576 Drugs for Rare Diseases
- Metadata Analysis of Phanerochaete Chrysosporium Gene Expression
- 2019 Medicaid Preapproval Criteria
- Mechanisms of Distribution of Mouse Β-Galactosidase in the Adult GM1
- Synthesis and Degradation of Hyaluronic Acid in the Cultured Fibroblasts of Marfan's Disease
- 8=Glucuronidase Deficiency in A
- Characterization of a Mucopolysaccharidosis Type I and Galnac Transferase Deficiency Double Knockout Mouse Karan Gera Iowa State University
- Human Α-L-Iduronidase Uses Its Own N-Glycan As a Substrate-Binding and Catalytic Module
- Downloaded from JGI IMG/M (Table 1)
- Mucolipidoses Overview: Past, Present, and Future
- Discovery and Characterization of Family 39 Glycoside Hydrolases from Rumen Anaerobic Fungi with Polyspecific Activity on Rare A
- Delivery of an Enzyme-IGFII Fusion Protein to the Mouse Brain Is Therapeutic for Mucopolysaccharidosis Type IIIB
- A Founding Member of a New Glycoside Hydrolase Family from the Anaerobic Fungus Neocallimastix Frontalis
- Metasecretome Phage Display: a New Approach for Mining Surface and Secreted Proteins from Microbial Communities
- Enzyme Related Therapies
- Leukocyte Enzymes in Birth Defects— a Review
- Dna Mutation Testing
- Corporate Medical Policy
- Directions For
- (12) United States Patent (10) Patent No.: US 8,232,073 B2 Crawford Et Al
- The Mom Na Hulludinio
- Mucopolysaccharidosis Type IIIB (Sanfilippo B): Identification of 18
- 2012 Abigail Esenam Asangba
- 2019-Cardon-Et-Al-Plant-Biotec
- Poster Session Abstracts
- Biochemical Evidence for Superior Correction of Neuronal Storage by Chemically Modified Enzyme in Murine Mucopolysaccharidosis VII
- Hurler Syndrome: A-L- Iduronidase Activity in Leukocytes As a Method for Heterozygote Detection
- (12) United States Patent (10) Patent No.: US 8,558,058 B2 H00d Et Al
- Metabolic Cardiomyopathy: a Review and Pooled Analysis
- Characterization of an MPS I-H Knock-In Mouse That Carries a Nonsense Mutation Analogous to the Human IDUA-W402X Mutation
- HYDROLASES Is a 2.0: Why His Almi
- Decreased Alpha-L-Iduronidase
- IDUA Gene Iduronidase, Alpha-L
- ENZYME REPLACEMENT THERAPY Policy Number: CS2019D0052L Effective Date: October 1, 2019
- Supporting Information
- Mucopolysaccharidosis Type IIIB and Galnac Transferase Double
- Genetic Testing of Mucopolysaccharidoses Disease Using Multiplex PCR- Based Panels of STR Markers: in Silico Analysis of Novel Mutations
- Newborn Screening for Lysosomal Storage Disorders in Belgium
- Positive Result Provider Fact Sheet Absent/Reduced Alpha-L-Iduonidase
- Cell-Specific Proteome Analyses of Human Bone Marrow
- Lysosmal Enzyme Specimen Collection Guide
- Alpha-Iduronidase Enzyme Activity (Mucopolysaccharidosis Type I)
- Identification of Four Recurrent IDUA Sequence Changes That Significantly Reduce Enzyme Activity
- Anti-Taliglucerase Alpha Antibodies Associated with Lower Efficacy of ERT and Onset of Autoimmune Thyroiditis in a Patient With
- Long-Term Neurological Effects of Bone Marrow Transplantation in a Canine Lysosomal Storage Disease
- L-Iduronidase in Maize for the Potential Treatment of a Human Lysosomal Storage Disease
- Mucopolysaccharidosis (Mps) Panel